Monoclonal Antibodies in Veterinary Health Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
CHAPTER 1. Industry Overview of Monoclonal Antibodies in Veterinary Health Market
1.1. Definition and Scope
1.1.1. Definition of Monoclonal Antibodies In Veterinary Health
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Monoclonal Antibodies in Veterinary Health Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Monoclonal Antibodies in Veterinary Health Market By Animal Type
1.2.3. Monoclonal Antibodies in Veterinary Health Market By Application
1.2.4. Monoclonal Antibodies in Veterinary Health Market By End-user
1.2.5. Monoclonal Antibodies in Veterinary Health Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Monoclonal Antibodies in Veterinary Health Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Monoclonal Antibodies in Veterinary Health Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Price Trend of Key Raw Material
3.8.1. Raw Material Suppliers
3.8.2. Proportion of Manufacturing Cost Structure
3.8.2.1. Raw Material
3.8.2.2. Labor Cost
3.8.2.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Monoclonal Antibodies in Veterinary Health Market By Animal Type
5.1. Introduction
5.2. Monoclonal Antibodies In Veterinary Health Revenue By Animal Type
5.2.1. Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast, By Animal Type, 2020-2032
5.2.2. Companion Animals
5.2.2.1. Companion Animals Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3. Livestock
5.2.3.1. Livestock Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 6. Monoclonal Antibodies in Veterinary Health Market By Application
6.1. Introduction
6.2. Monoclonal Antibodies In Veterinary Health Revenue By Application
6.2.1. Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast, By Application, 2020-2032
6.2.2. Dermatology
6.2.2.1. Dermatology Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3. Pain
6.2.3.1. Pain Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.4. Others
6.2.4.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 7. Monoclonal Antibodies in Veterinary Health Market By End-user
7.1. Introduction
7.2. Monoclonal Antibodies In Veterinary Health Revenue By End-user
7.2.1. Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast, By End-user, 2020-2032
7.2.2. Veterinary Hospitals
7.2.2.1. Veterinary Hospitals Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.3. Others
7.2.3.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 8. North America Monoclonal Antibodies in Veterinary Health Market By Country
8.1. North America Monoclonal Antibodies in Veterinary Health Market Overview
8.2. U.S.
8.2.1. U.S. Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Animal Type, 2020-2032
8.2.2. U.S. Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Application, 2020-2032
8.2.3. U.S. Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By End-user, 2020-2032
8.3. Canada
8.3.1. Canada Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Animal Type, 2020-2032
8.3.2. Canada Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Application, 2020-2032
8.3.3. Canada Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By End-user, 2020-2032
8.4. North America PEST Analysis
CHAPTER 9. Europe Monoclonal Antibodies in Veterinary Health Market By Country
9.1. Europe Monoclonal Antibodies in Veterinary Health Market Overview
9.2. U.K.
9.2.1. U.K. Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Animal Type, 2020-2032
9.2.2. U.K. Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Application, 2020-2032
9.2.3. U.K. Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By End-user, 2020-2032
9.3. Germany
9.3.1. Germany Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Animal Type, 2020-2032
9.3.2. Germany Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Application, 2020-2032
9.3.3. Germany Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By End-user, 2020-2032
9.4. France
9.4.1. France Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Animal Type, 2020-2032
9.4.2. France Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Application, 2020-2032
9.4.3. France Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By End-user, 2020-2032
9.5. Spain
9.5.1. Spain Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Animal Type, 2020-2032
9.5.2. Spain Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Application, 2020-2032
9.5.3. Spain Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By End-user, 2020-2032
9.6. Rest of Europe
9.6.1. Rest of Europe Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Animal Type, 2020-2032
9.6.2. Rest of Europe Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Application, 2020-2032
9.6.3. Rest of Europe Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By End-user, 2020-2032
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Monoclonal Antibodies in Veterinary Health Market By Country
10.1. Asia Pacific Monoclonal Antibodies in Veterinary Health Market Overview
10.2. China
10.2.1. China Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Animal Type, 2020-2032
10.2.2. China Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Application, 2020-2032
10.2.3. China Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By End-user, 2020-2032
10.3. Japan
10.3.1. Japan Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Animal Type, 2020-2032
10.3.2. Japan Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Application, 2020-2032
10.3.3. Japan Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By End-user, 2020-2032
10.4. India
10.4.1. India Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Animal Type, 2020-2032
10.4.2. India Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Application, 2020-2032
10.4.3. India Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By End-user, 2020-2032
10.5. Australia
10.5.1. Australia Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Animal Type, 2020-2032
10.5.2. Australia Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Application, 2020-2032
10.5.3. Australia Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By End-user, 2020-2032
10.6. South Korea
10.6.1. South Korea Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Animal Type, 2020-2032
10.6.2. South Korea Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Application, 2020-2032
10.6.3. South Korea Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By End-user, 2020-2032
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Animal Type, 2020-2032
10.7.2. Rest of Asia-Pacific Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Application, 2020-2032
10.7.3. Rest of Asia-Pacific Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By End-user, 2020-2032
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Monoclonal Antibodies in Veterinary Health Market By Country
11.1. Latin America Monoclonal Antibodies in Veterinary Health Market Overview
11.2. Brazil
11.2.1. Brazil Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Animal Type, 2020-2032
11.2.2. Brazil Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Application, 2020-2032
11.2.3. Brazil Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By End-user, 2020-2032
11.3. Mexico
11.3.1. Mexico Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Animal Type, 2020-2032
11.3.2. Mexico Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Application, 2020-2032
11.3.3. Mexico Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By End-user, 2020-2032
11.4. Rest of Latin America
11.4.1. Rest of Latin America Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Animal Type, 2020-2032
11.4.2. Rest of Latin America Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Application, 2020-2032
11.4.3. Rest of Latin America Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By End-user, 2020-2032
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Monoclonal Antibodies in Veterinary Health Market By Country
12.1. Middle East & Africa Monoclonal Antibodies in Veterinary Health Market Overview
12.2. GCC
12.2.1. GCC Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Animal Type, 2020-2032
12.2.2. GCC Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Application, 2020-2032
12.2.3. GCC Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By End-user, 2020-2032
12.3. South Africa
12.3.1. South Africa Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Animal Type, 2020-2032
12.3.2. South Africa Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Application, 2020-2032
12.3.3. South Africa Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By End-user, 2020-2032
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Animal Type, 2020-2032
12.4.2. Rest of Middle East & Africa Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By Application, 2020-2032
12.4.3. Rest of Middle East & Africa Monoclonal Antibodies In Veterinary Health Revenue (USD Million) and Forecast By End-user, 2020-2032
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Monoclonal Antibodies in Veterinary Health Market
13.1. Monoclonal Antibodies in Veterinary Health Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Monoclonal Antibodies in Veterinary Health Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Zoetis
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Million), 2022
14.1.3.2. Zoetis 2022 Monoclonal Antibodies In Veterinary Health Business Regional Distribution
14.1.4. Product/Service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. Elanco Animal Health
14.3. Boehringer Ingelheim Animal Health
14.4. Merck Animal Health
14.5. Bayer Animal Health
14.6. Vetoquinol
14.7. Virbac
14.8. IDEXX Laboratories
14.9. Dechra Pharmaceuticals
14.10. Heska Corporation
14.11. Kindred Biosciences
Frequently Asked Questions
What was the market size of the global monoclonal antibodies in veterinary health in 2022?
The market size of monoclonal antibodies in veterinary health was USD 701 Million in 2022.
What is the CAGR of the global Monoclonal Antibodies in Veterinary Health Market from 2023 to 2032?
The CAGR of monoclonal antibodies in veterinary health is 16.6%during the analysis period of 2023 to 2032.
Which are the key players in the Monoclonal Antibodies in Veterinary Health Market?
The key players operating in the global market are including Zoetis, Elanco Animal Health, Boehringer Ingelheim Animal Health, Merck Animal Health, Bayer Animal Health, Vetoquinol, Virbac, IDEXX Laboratories, Dechra Pharmaceuticals, Heska Corporation, and Kindred Biosciences.
Which region dominated the global Monoclonal Antibodies in Veterinary Health Market share?
North America held the dominating position in monoclonal antibodies in veterinary health industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of monoclonal antibodies in veterinary health during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global monoclonal antibodies in veterinary health industry?
The current trends and dynamics in the monoclonal antibodies in veterinary health industry include increasing demand for advanced veterinary healthcare, and rising prevalence of chronic and infectious diseases in animals.
Which application held the maximum share in 2022?
The dermatology application held the maximum share of the monoclonal antibodies in veterinary health industry.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
